SCHEMBL911575

SCHEMBL911575

CCc1cc(C)cc(O)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.57
PTGS2 P35354 4/20 0.41
CYP3A4 P08684 1/20 0.41
HCAR1 Q9BXC0 1/20 0.41
ACHE P22303 4/20 0.40
TRPA1 O75762 1/20 0.39
LTA4H P09960 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
ALOX5 P09917 1/20 0.38
PTGS1 P23219 1/20 0.38
HSD17B1 P14061 1/20 0.38
HSD17B2 P37059 1/20 0.38
NR1H2 P55055 1/20 0.38
NR1H3 Q13133 1/20 0.38
PGK1 P00558 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31200644 1.00 ALDH1A1 (0.57) ALDH1A1PTGS2CYP3A4HCAR1ACHE
SCHEMBL14134419 0.84 ALDH1A1 (0.39) ALDH1A1PTGS2TRPA1ALOX5PTGS1
SCHEMBL207718 0.84 PTGS2 (0.48) ALDH1A1PTGS2CYP3A4ACHETRPA1
SCHEMBL69634 0.84 ACHE (0.55) ALDH1A1PTGS2CYP3A4ACHETRPA1
SCHEMBL29215628 0.82 ALDH1A1 (0.60) ALDH1A1PTGS2CYP3A4HCAR1ACHE
SCHEMBL30899188 0.82 ALDH1A1 (0.60) ALDH1A1PTGS2CYP3A4HCAR1ACHE
SCHEMBL3959592 0.81 PTGS2 (0.54) ALDH1A1PTGS2CYP3A4HCAR1ACHE
SCHEMBL5490825 0.81 PGK1 (0.44) ALDH1A1PTGS2TRPA1ALOX5PTGS1
SCHEMBL168174 0.81 PGK1 (0.44) ALDH1A1PTGS2TRPA1ALOX5PTGS1
SCHEMBL271754 0.81 ALDH1A1 (0.42) ALDH1A1PTGS2ACHETRPA1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 560 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122080054-A Method for synthesizing tri (3, 4-methyl ethyl) phenol phosphate 2026-05-26 CN claimed
CN-122011307-A Method for synthesizing phenolic resin from 2,4/2, 5-methyl ethyl phenol 煤炭科学技术研究院有限公司 2026-05-12 CN claimed
CN-122011306-A Method for synthesizing phenolic resin from mixed phenol containing 2,4, 6-tricresyl 煤炭科学技术研究院有限公司 2026-05-12 CN claimed
CN-113396171-B Process for producing polyphenol derivative, and resin composition containing polyphenol derivative 出光兴产株式会社 2025-03-28 CN claimed
CN-119490388-A Method for separating and obtaining phenolic substances from phenol-containing coal tar 煤炭科学技术研究院有限公司 2025-02-21 CN claimed
CN-119431113-A Method for refining 2,3, 5-tricresyl and 3-methyl-5-ethylphenol from trimethylphenol mixture 煤炭科学技术研究院有限公司 2025-02-14 CN claimed
CN-119431115-A Impurity removing method for mixed phenol extracted from coal tar 煤炭科学技术研究院有限公司 2025-02-14 CN claimed
CN-119060278-A Method for synthesizing photoresist by using m-p-ethyl phenol mixture 盐城工学院 2024-12-03 CN claimed
US-20240376284-A1 Method for Screening Solvent for Acrylonitrile Butadiene Styrene Copolymer Extraction, Recycling Method for Waste Material, and Recycled Acrylonitrile Butadiene Styrene Copolymer and Composition LG CHEM, LTD. (KR) 2024-11-14 US claimed
US-20240376285-A1 Method for Screening Solvent for Extracting Acrylonitrile Butadiene Styrene Copolymer, Method for Recycling Waste, Recycled Acrylonitrile Butadiene Styrene Copolymer, and Composition LG CHEM, LTD. (KR) 2024-11-14 US claimed
WO-2001077079-A2 POLYCYCLIC ARYL AND HETEROARYL SUBSTITUTED 4-PYRIDONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2001-10-18 WO claimed
WO-2001077097-A2 POLYCYCLIC ARYL AND HETEROARYL SUBSTITUTED 4-PYRONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2001-10-18 WO claimed
WO-2001068605-A1 POLYCYCLIC ARYL AND HETEROARYL SUBSTITUTED BENZENES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2001-09-20 WO claimed
US-20010018446-A1 Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity G.D. SEARLE & CO. (US) 2001-08-30 US claimed
EP-1115695-A1 (R)-CHIRAL HALOGENATED 1-SUBSTITUTEDAMINO-(N+1)-ALKANOLS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY Monsanto Company (US) 2001-07-18 EP claimed
EP-1115693-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY Monsanto Company (US) 2001-07-18 EP claimed
EP-1115694-A1 SUBSTITUTED N-ALIPHATIC-N-AROMATIC (TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY Monsanto Company (US) 2001-07-18 EP claimed
WO-2000018724-A1 (R)-CHIRAL HALOGENATED 1-SUBSTITUTEDAMINO-(n+1)-ALKANOLS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY MONSANTO COMPANY (US) 2000-04-06 WO claimed
WO-2000018723-A1 SUBSTITUTED N-ALIPHATIC-N-AROMATIC TERTIARY-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY MONSANTO COMPANY (US) 2000-04-06 WO claimed
WO-2000018721-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL TERTIARY-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY MONSANTO COMPANY (US) 2000-04-06 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010018446-A1 Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity CETP, DBI, MTTP ALDH1A1 2624/4885PTGS2 4509/4885CYP3A4 2162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.